News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Tofacitinib may promote HBV reactivation in certain RA patients
24 Sep 2021
Use of tofacitinib for rheumatoid arthritis (RA) may lead to reactivation of hepatitis B virus (HBV), especially among hepatitis B surface antigen-positive (HBsAg+) and HBsAg-negative/hepatitis B core antibody-positive (HBsAg–/HBcAb+) patients, according to a study from Taiwan.
Tofacitinib may promote HBV reactivation in certain RA patients
24 Sep 2021
MV130 immunotherapy prevents COPD exacerbations
24 Sep 2021
byElaine Soliven
Treatment with MV130, a sublingual bacterial immunotherapy, reduces the number of exacerbations in patients with chronic obstructive pulmonary disease (COPD), according to a recent study presented at ERS 2021.







